Gabaergic Neuron Vulnerability is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
This page provides comprehensive information about the cell type. See the content below for detailed information. [1]
GABAergic neurons are inhibitory neurons that exhibit selective vulnerability in various neurodegenerative diseases. Their dysfunction contributes to network hyperexcitability, seizures, and cognitive impairment. [2]
| Taxonomy | ID | Name / Label |
|---|---|---|
| Cell Ontology (CL) | CL:0000617 | GABAergic neuron |
| Database | ID | Name | Confidence | [3]
|----------|----|------|------------|
| Cell Ontology | CL:0000617 | GABAergic neuron | Medium |
Parvalbumin-positive interneurons
Somatostatin interneurons
Striatal medium spiny neurons (indirect pathway)
Fast-spiking parvalbumin interneurons
The study of Gabaergic Neuron Vulnerability has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Brady, D.R., & Mufson, E.J. (1997). Parvalbumin-immunoreactive neurons in the hippocampal formation in Alzheimer's disease. Neuroscience. 1997. ↩︎
Heckers, S., et al. (1991). Neuroscience Letters. 1991. ↩︎
Rudolph, U., & Möhler, H. (2013). GABA-based therapeutic approaches: GABA A receptor subtypes. Current Opinion in Pharmacology. 2013. ↩︎